GUARDANT HEALTH, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $10.36M, a 34.92% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $5.91M, a 31.02% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $7.68M, a 6.49% increase year-over-year.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $13.59M, a 15.92% increase from fiscal 2024.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $11.72M, a 15.41% increase from fiscal 2023.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $10.15M, a 9.00% increase from fiscal 2022.
- GUARDANT HEALTH, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $9.32M, a 4.48% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $10.36M 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $13.59M 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | |
| 2025-06-30 | $7.68M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $11.72M 10-K · filed 2026-02-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | |
| 2024-06-30 | $7.21M 10-Q · filed 2025-07-30 | |
| 2023-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.15M 10-K · filed 2026-02-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | |
| 2023-06-30 | $6.70M 10-Q · filed 2024-08-07 | |
| 2022-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $9.32M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | |
| 2022-06-30 | $5.74M 10-Q · filed 2023-08-03 | |
| 2021-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $9.75M 10-K · filed 2024-02-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | |
| 2021-06-30 | $5.40M 10-Q · filed 2022-08-04 | |
| 2020-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $7.09M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2020-06-30 | $3.96M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.39M 10-K · filed 2022-02-24 |
| 2019-09-30 | $3.19M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | |
| 2019-03-31 | $1.93M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |